7 Small-Cap Stocks With Significant Upside Potential in 2024

7 Small-Cap Stocks With Significant Upside Potential in 2024

Explore stocks on Coinbase

Investing in small-cap stocks offers multiple advantages for those looking to diversify their portfolios with potential high-growth opportunities efficiently. Small-cap stocks strike a unique balance between the relatively nascent microcap sphere and the more mature mid and large-cap segments. They boast the established foundations needed for stability yet remain agile enough to promise significant long and medium-term growth prospects. This category is especially appealing because these companies, still in their growth phases, are primed to deliver superior returns compared to their larger counterparts.

Small-cap stocks present a golden opportunity for investors to discover undervalued market players, often overlooked by analysts, and invest in the early stages of what could be tomorrow’s industry leaders. Despite their inherent volatility, these stocks are key to achieving a well-rounded, growth-oriented investment strategy that can effectively outperform the broader market over time.

Small-Cap Stocks To Buy: Dorian (LPG)

Ship tanker gas LPG, Aerial view Liquefied Petroleum Gas (LPG) tanker, Tanker ship logistic and transportation business oil and gas industry, Loading arm oil and gas offshore platforms.
Ship tanker gas LPG, Aerial view Liquefied Petroleum Gas (LPG) tanker, Tanker ship logistic and transportation business oil and gas industry, Loading arm oil and gas offshore platforms.

Source: Avigator Fortuner / Shutterstock.com

Dorian (NYSE:LPG) efficiently sails through the lucrative waters of liquefied petroleum gas transportation with remarkable aplomb, with its fleet of 25 large gas carriers (VLGCs), boasting a combined capacity of 2.1 million cubic meters. This powerful asset base positions the firm to efficiently capitalize on the growing demand and prices of fuel products, underlining its prowess in navigating the dynamics of global energy markets.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

In an enviable display of operational excellence, Dorian LPG reported a near-record time charter equivalent (TCE) of $76,337 per day during the third quarter, a testament to its robust market positioning and savvy business strategy. This remarkable performance resulted in an adjusted EBITDA of $133 million, the highest in its history. Moreover, LPG stock trades at a remarkable 4.6 times Non-GAAP forward earnings estimates, roughly 52.6% lower than its 5-year average. Additionally, the stock is up almost 49% in the past six months, which makes it an excellent time to add it to your portfolios.

Zymeworks’ (ZYME)

A variety of pills, pill bottles, and droppers arranged on a table in multiple bright colors.
A variety of pills, pill bottles, and droppers arranged on a table in multiple bright colors.

Source: Shutterstock

Zymeworks’ (NASDAQ:ZYME) is a true trailblazer in the biopharmaceutical sector with a keen focus on cancer treatment innovations. Through its strategic partnerships, including a major collaboration with Johnson & Johnson (NYSE:JNJ), the company is advancing its presence in preclinical and phase one trials, showcasing its commitment to revolutionizing cancer care. Moreover, the recent earnings report for the third quarter paints a promising picture of Zymeworks’ trajectory, with total revenue skyrocketing more than sixfold along with a 40% reduction in net loss compared to the prior-year period.